Aker Biomarine AS Cash Flow-to-Debt Ratio
Aker Biomarine AS cash flow-to-debt ratio. Aker Biomarine AS (AKBM) has a Cash Flow-to-Debt Ratio of -0.03x as of June 2025, meaning its operating cash flow of Nkr-6.90 Million could theoretically repay 0% of its total liabilities (Nkr237.50 Million) in one year. Check AKBM total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Aker Biomarine AS (2016–2024)
Cash flow-to-debt ratio of Aker Biomarine AS from 2016 to 2024. Historical debt coverage capacity for Aker Biomarine AS across 9 annual periods. Check cash flow quality index of Aker Biomarine AS to evaluate the quality of earnings relative to operating cash generation.
Aker Biomarine AS Cash Flow-to-Debt Ratio by Year (2016–2024)
Aker Biomarine AS cash flow-to-debt ratio by year from 2016 to 2024. Year-by-year debt coverage analysis for Aker Biomarine AS. For the full cash flow conversion analysis, see Aker Biomarine AS (AKBM) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (NOK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.06x | Nkr12.20 Million | Nkr213.50 Million | ▼ -44.5% |
| 2023 | 0.10x | Nkr47.40 Million | Nkr460.60 Million | ▲ +203.8% |
| 2022 | 0.03x | Nkr15.10 Million | Nkr445.80 Million | ▲ +1698.7% |
| 2021 | 0.00x | Nkr729.00K | Nkr387.12 Million | ▲ +101.2% |
| 2020 | -0.16x | Nkr-51.04 Million | Nkr327.26 Million | ▼ -781.4% |
| 2019 | 0.02x | Nkr12.31 Million | Nkr537.68 Million | ▼ -27.1% |
| 2018 | 0.03x | Nkr7.89 Million | Nkr251.43 Million | ▲ +8.9% |
| 2017 | 0.03x | Nkr9.17 Million | Nkr318.12 Million | ▼ -71.6% |
| 2016 | 0.10x | Nkr20.88 Million | Nkr205.32 Million | — |